TAGLine 2025: A Year of Action
TAGLine 2025 documents a year of action as Treatment Action Group defended science, confronted attacks on public health, and fought to protect communities impacted by HIV, TB, and HCV.
What Could Go Right? Partnering with Communities and Civil Society for New TB Vaccines
New tuberculosis (TB) vaccines could be realized as soon as 2028 — radically reshaping the journey to eliminate TB. Communities and civil society organizations are poised to play a vital role in the introduction of a future TB vaccine as central protagonists of this next chapter for TB elimination.
From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL
From Forest to Factory: Tracing the Supply Chains for Two Modern Adjuvants of Global Health Importance — QS-21 and MPL provides a first of its kind analysis of the global supply chains of two key adjuvants used in several of the world’s most important vaccines.
TAG Condemns the ACIP Decision to Remove Birth Vaccination for Hepatitis B Virus (HBV) from Federal Guidelines, Calls for Senate Oversight Hearings and the Immediate Resignation of HHS Secretary Robert F. Kennedy, Jr.
On Friday, RFK Jr’s vaccine denialist-dominated Advisory Committee on Immunization Practices (ACIP) voted to no longer recommend immediate post-partum / birth vaccination of babies with hepatitis B virus (HBV) vaccine.
Governments and Donors Must Step Forward to Fund Global, Equitable Access to New TB Vaccines in Development
Treatment Action Group (TAG) welcomes the report published today by the World Health Organization TB Vaccine Accelerator Council on how to finance global, equitable access to new TB vaccines.
Treatment Action Group Statement on Termination of HIV Vaccine Research Funding
On Friday May 30, it was reported that National Institutes of Health (NIH) leadership has unilaterally terminated funding for HIV vaccine research consortia that were making significant progress toward solving the stern challenge of inducing protective broadly neutralizing antibodies against the virus.
2025 Comments Delivered at the WHO Director General’s TB Vaccine Accelerator Council
These are the remarks delivered by Mike Frick, TAG’s TB co-director, who was speaking as a civil society representative, at the 3rd meeting of the WHO Director-General’s TB Vaccine Accelerator Council on May 20, 2025 in Geneva, Switzerland.
TAG Launches TB Vaccines Pipeline Report
TAG is pleased to share the latest edition of our Tuberculosis Vaccines Pipeline Report, written by TB project co-director Mike Frick. The report provides the latest information on 17 vaccine candidates under clinical development and summarizes ongoing, planned, and recently completed clinical trials in two comprehensive tables.
Cheat Sheets for Tuberculosis Activists
TAG’s Cheat Sheets for Tuberculosis Activists are designed to help advocates navigate the range of tools in use and in the research pipeline.
Comments Delivered at the WHO Director-General’s TB Vaccine Accelerator Council
These are the remarks delivered by Mike Frick, TAG’s TB co-director, who was speaking as a civil society representative, at the 2nd meeting of the WHO Director-General’s TB Vaccine Accelerator Council in Geneva Switzerland.